Danaher Corporation $DHR Stock Holdings Raised by Choreo LLC

Key Points

• Choreo LLC increased its Danaher stake by 29.2% in the third quarter, bringing its holdings to 19,885 shares valued at approximately $4.4 million. Institutional investors and hedge funds collectively own 79.05% of Danaher.
• Danaher reported quarterly earnings of $2.11 per share, beating estimates of $1.92, while revenue rose 8.3% year over year to $6.55 billion. The company also declared a quarterly dividend of $0.40 per share.
• Analyst sentiment remains favorable, with a consensus “Moderate Buy” rating and an average price target of $242.91; meanwhile, Danaher’s chief accounting officer sold 7,598 shares at an average price of $234.56.

Choreo LLC increased its stake in shares of Danaher Corporation (NYSE:DHR - Free Report) by 29.2% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 19,885 shares of the conglomerate's stock after acquiring an additional 4,494 shares during the quarter. Choreo LLC's holdings in Danaher were worth $4,405,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently bought and sold shares of the stock. Main Street Group LTD bought a new position in shares of Danaher during the 1st quarter worth about $25,000. N.E.W. Advisory Services LLC bought a new stake in Danaher during the second quarter worth about $25,000. Marquette Asset Management LLC increased its holdings in shares of Danaher by 192.1% during the third quarter. Marquette Asset Management LLC now owns 111 shares of the conglomerate's stock worth $25,000 after buying an additional 73 shares in the last quarter. Evolution Wealth Management Inc. grew its holdings in shares of Danaher by 208.0% during the first quarter. Evolution Wealth Management Inc. now owns 154 shares of the conglomerate's stock worth $29,000 after purchasing an additional 104 shares during the last quarter. Finally, Field & Main Bank bought a new position in shares of Danaher in the second quarter worth about $29,000. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Danaher Price Performance

Shares of NYSE DHR opened at $232.22 on Friday. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.63 and a quick ratio of 1.29. The stock has a market capitalization of $163.37 billion, a PE ratio of 38.01, a P/E/G ratio of 2.92 and a beta of 0.76. The business has a fifty day moving average price of $218.92 and a two-hundred day moving average price of $201.77. Danaher Corporation has a fifty-two week low of $160.93 and a fifty-two week high of $242.80.

Danaher (NYSE:DHR - Get Free Report) last announced its quarterly earnings results on Wednesday, October 21st. The conglomerate reported $2.11 EPS for the quarter, beating analysts' consensus estimates of $1.92 by $0.19. The company had revenue of $6.55 billion during the quarter, compared to analysts' expectations of $6.56 billion. Danaher had a return on equity of 11.17% and a net margin of 16.91%. Danaher's revenue was up 8.3% compared to the same quarter last year. During the same period in the prior year, the company earned $1.89 EPS. As a group, equities analysts predict that Danaher Corporation will post 8.59 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, October 30th. Stockholders of record on Wednesday, September 30th were issued a dividend of $0.40 per share. The ex-dividend date was Wednesday, September 30th. This represents a $1.60 annualized dividend and a dividend yield of 0.7%. Danaher's dividend payout ratio is currently 26.19%.

Analysts Set New Price Targets

DHR has been the subject of several research reports. Robert W. Baird lifted their target price on Danaher from $246.00 to $254.00 and gave the company an "outperform" rating in a research note on Thursday, October 22nd. Barclays upped their target price on shares of Danaher from $255.00 to $260.00 and gave the company an "overweight" rating in a research note on Thursday, October 22nd. Weiss Ratings upgraded Danaher from a "hold (c-)" rating to a "hold (c)" rating in a report on Wednesday, September 16th. Guggenheim raised their price target on Danaher from $200.00 to $250.00 and gave the stock a "buy" rating in a research report on Thursday, October 1st. Finally, Evercore restated an "outperform" rating and set a $230.00 target price on shares of Danaher in a report on Monday, July 6th. Eighteen research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $242.91.

Insider Activity

In other news, CAO Christopher Bouda sold 7,598 shares of the stock in a transaction dated Wednesday, October 28th. The shares were sold at an average price of $234.56, for a total transaction of $1,782,186.88. Following the transaction, the chief accounting officer owned 9,107 shares of the company's stock, valued at $2,136,137.92. This represents a 45.48% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 10.80% of the stock is owned by company insiders.

Danaher Company Profile

Danaher Corporation NYSE: DHR is a global science and technology company that develops products, services and solutions for the life sciences, biotechnology and diagnostics markets. Its offerings help researchers, pharmaceutical and biotechnology companies, healthcare providers and other organizations conduct scientific research, develop and manufacture medicines, and diagnose disease.

The company operates through businesses that provide bioprocessing equipment and technologies, laboratory instruments, consumables, analytical tools and clinical diagnostic systems.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.